GlassScriptPhysician profile
Conor Fowler
NPI 1871120170
$3,508.13
in general payments reported to CMS, 2019-2025
8 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,466 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,980 · Travel and Lodging: $1,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,980.15 |
| Travel and Lodging | $1,527.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,778.86 | 2024-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $1,124.71 | 2024 | Intellis Adaptivestim |
| Abbott Laboratories | $235.26 | 2025 | Proclaim |
| Abbvie INC. | $169.85 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $143.55 | 2024-2025 | |
| Virtus Pharmaceuticals LLC | $21.32 | 2024 | Levorphanol Tartrate |
| Electronic Waveform Lab, INC. | $18.56 | 2025 | |
| Tersera Therapeutics LLC | $16.02 | 2025 | Prialt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conor Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.